Gemphire Therapeutics Inc. Underwriting Agreements
5 Contracts & Agreements
- Underwriting Agreement dated as of November 4, 2022, by and between NeuroBo Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 8, 2022)
- Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 3, 2022)
- Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc (Filed With SEC on October 24, 2022)
- 3,142,858 Shares Gemphire Therapeutics Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 12, 2018)
- [] Shares Gemphire Therapeutics Inc. UNDERWRITING AGREEMENT (Filed With SEC on April 18, 2016)
